Welcome to the latest issue of EMJ Cardiology! We are proud to share with you an impressive collection of new and interesting research and review articles, alongside our independent review of the European Society of Cardiology (ESC) Congress 2020 with research and breaking news from the virtual event.
+ CONGRESS REVIEW
Review of the European Society of Cardiology (ESC) Congress 2020,
28th August–1st September
+ CONGRESS FEATURE
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
Anaya Malik
+ SYMPOSIUM REVIEW
Therapeutic Advances in Patients with Heart Failure with Reduced Ejection Fraction Who Have Had a Previous Worsening Heart Failure Event
+ POSTER REVIEWS
New Insights into Icosapent Ethyl for Patients with Residual Cardiovascular Risk
+ CONGRESS INTERVIEW
Dan Atar, Stephan Achenbach, and Jose Zamorano
+ INTERVIEWS
Key Findings from the EXPLORER-HCM Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: Insights From the Principal Investigator
Iacopo Olivotto
+ ARTICLES
Editor’s Pick: Artificial Intelligence in Patients with Congenital Heart Disease: Where Do We Stand?
Pool et al.
Sex Differences in Heart Failure with Preserved Ejection Fraction Therapy: Potential Mechanisms and Clinical Implications
Meyer and Beale
Acute Severe Mitral Regurgitation Secondary to Haemophilus parainfluenzae Infective Endocarditis
Kelley et al.
The Evolution and Future Direction of The Cardiac Biomarker
McDonaugh and Whyte
High-Density Lipoproteins and Cardiovascular Disease
Nicholls et al.
Raiders of the Lost Wire
Salazar et al.
A Clinical Review of Ventricular Arrhythmias in Patients with Congestive Heart Failure
Al-Hadithi and Boyle
Edge-To-Edge Repair After Prior Left-Sided Pneumonectomy
Abdel-Hadi et al.
"Our Editor’s Pick for this publication is the cutting-edge review by Pool et al. ‘Artificial Intelligence in Patients with Congenital Heart Disease: Where Do We Stand?’"
Spencer Gore
Chief Executive Officer, EMG-Health
ALSO AVAILABLE
Follow this link to read EMJ Hematology, which contains a congress session review of a presentation on coagulopathy and hyperinflammation in coronavirus disease (COVID-19) presented in EHA25 this year. Read this journal for discussion points to spark conversation within the cardiology community.